Texas HB 816: Relating to warning labels for opioid prescription drugs.

Status: Referred to Public Health (as of 2023-03-01)

State: Texas · Session: 88 · Bill: HB 816

Subjects: Alcoholism & Drug Abuse (I0030), Health--Other Diseases & Medical Conditions (I0383), MEDICINE & PRESCRIPTION DRUGS (S7338), PACKAGING & LABELING REQUIREMENTS (S0339), PHARMACIES & PHARMACISTS (S1192), PHARMACY, TEXAS STATE BOARD OF (V0022)

Sponsors: Thierry

View Texas HB 816 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.